Nivolumab Biosimilar, Anti-Human PD-1 Monoclonal Antibody

Nivolumab biosimilar is a recombinant humanized IgG4 kappa monoclonal antibody. The cheapest research grade nivolumab biosimilar, human PD-1 monoclonal antibody, neutralization, in vivo functional assays such as bioanalytical PK and ADA assays, and those in vitro and in vivo assays for studying biological pathways affected by nivolumab. The research grade nivolumab biosimilar protein is for research use only.

Synonyms: programmed cell death protein 1, PD1, PD-1, PDCD1, hPD1, CD279, cluster of differentiation 279, Programmed Cell Death 1 protein, CD279 antigen, HPD-L, SLEB2, hPD-1, hPD-l, hSLE1